loading

Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
49.83%
68.73
45.87 37.96 20.04 12.50
Operating Expenses
27.09%
131.28
103.30 107.31 103.80 102.08
Benefits Costs and Expenses
-321.03
- - 104.89 -
Costs And Expenses
20.43%
124.40
103.30 107.31 104.89 102.08
Operating Income/Loss
8.92%
-62.55
-57.43 -69.35 -83.76 -89.58
Nonoperating Income/Loss
66.19%
-5.466
-3.289 -2.494 -1.089 5.451
Income/Loss From Continuing Operations Before Tax
749.69%
389.76
45.87 -71.85 -84.85 12.50
Income Tax Expense/Benefit
0.433
- - - -
Income/Loss From Continuing Operations After Tax
12.02%
-68.01
-60.72 -71.85 -84.85 -84.13
Net Income/Loss
12.02%
-68.01
-60.72 -71.85 -84.85 -84.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.89%
0.0944
86.62 86.34 86.17 85.43
Diluted Average Shares
99.89%
0.0944
86.62 86.34 86.17 85.43
Basic Earnings Per Share
11.43%
-0.78
-0.70 -0.83 -0.98 -0.98
Diluted Earnings Per Share
11.43%
-0.78
-0.70 -0.83 -0.98 -0.98
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):